ChemoCentryx ContactKeep Me PostedSite Map
Medicines in MotionChemoCentryx is a clinical stage focused pharmaceutical company creating small molecule medicines for autoimmune diseases, inflammatory disorders and oncology.
Announcement
PROTECT-1 Phase II/III Induction-Stage Results for ChemoCentryx's Traficet-EN™ Presented in Oral Session at DDW 2009 Conference
ChemoCentryx's Traficet-EN™ Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week
ChemoCentryx Identifies Novel Small Molecule C5aR Antagonist
  More News >
GET MORE information about ChemoCentryx's products. LEARN ABOUT chemokines and diseases. FIND OUT about clinical trials of Traficet-EN™ for IBD.
GET MORE information about ChemoCentryx's products. LEARN ABOUT chemokines and diseases. FIND OUT about clinical trials of Traficet-EN for IBD.

© 2009 ChemoCentryx, Inc. Legal | Site User's Guide